NCT02374775

Brief Summary

The EMERALD trial is a multinational, multicenter study. The patients presented with AMI/definite evidence of plaque rupture and had underwent coronary CT angiography from 1 month to 2 year prior to the event will be retrospectively searched. Plaques in the non-culprit vessels will be regarded as internal control to the ruptured plaque in the culprit vessel.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
77

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Sep 2014

Typical duration for all trials

Geographic Reach
1 country

2 active sites

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2014

Completed
21 days until next milestone

First Submitted

Initial submission to the registry

September 22, 2014

Completed
5 months until next milestone

First Posted

Study publicly available on registry

March 2, 2015

Completed
2.5 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2017

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2017

Completed
Last Updated

April 4, 2017

Status Verified

April 1, 2017

Enrollment Period

3 years

First QC Date

September 22, 2014

Last Update Submit

April 2, 2017

Conditions

Keywords

axial plaque stresspressurepressure gradientcoronary plaqueplaque ruptureacute coronary syndromeacute myocardial infarctioncomputational fluid dynamicscoronary computed tomography angiographywall shear stress

Outcome Measures

Primary Outcomes (2)

  • The difference of area under curve between prediction model with adverse plaque characteristics and model with adverse plaque characteristics and hemodynamic forces

    Model 1 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography Model 2 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography + Hemodynamic forces defined by computational fluid dynamics

    from 1 month - 2 year

  • The difference of net reclassification index between prediction model with adverse plaque characteristics and model with adverse plaque characteristics and hemodynamic forces

    Model 1 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography Model 2 : percent diameter stenosis + adverse plaque characteristics defined by CT angiography + Hemodynamic forces defined by computational fluid dynamics

    from 1 month - 2 year

Secondary Outcomes (8)

  • The best cut-off value of axial plaque stress to induce plaque rupture.

    from 1 month - 2 year

  • The threshold of the plaque vulnerability (Housefiled unit of the plaque on CT) to induce rupture.

    from 1 month - 2 year

  • The independent predictors for the plaque rupture using generalized estimating equation, and the c-index of the predicting models.

    from 1 month - 2 year

  • The validity of rupture risk score which constructed from the predicting model.

    from 1 month - 2 year

  • The differences in other hemodynamic parameters for example, pressure gradient, delta pressure, FFRCT, average and peak wall shear stress between Group A and Group B.

    from 1 month - 2 year

  • +3 more secondary outcomes

Study Arms (2)

Group A (Culprit lesion)

The plaque in the culprit vessel of acute myocardial infarction will be defined the Group A.

Group B (Non-culprit lesion)

The plaque in the non-culprit vessel of acute myocardial infarction will be defined as internal control, Group B.

Eligibility Criteria

Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients who experienced acute myocardial infarction from 2010-2014 whose diagnosis have confirmed by invasive coronary angiography with or without IVUS or OCT evaluation, and who underwent coronary CT angiography from 1 month to 2 year prior to the acute myocardial infarction event. Acute coronary syndrome without cardiac enzyme elevation (unstable angina) will be excluded. The time limit of the coronary CT angiography prior to the event is from 1 month to 2 year. Participating center will perform abovementioned search process.

You may qualify if:

  • Patients who experienced acute myocardial infarction from 2010-2014 whose diagnosis have confirmed by invasive coronary angiography with or without IVUS or OCT evaluation, and who underwent coronary CT angiography from 1 month to 2 year prior to the acute myocardial infarction event.

You may not qualify if:

  • Acute coronary syndrome without cardiac enzyme elevation (unstable angina)
  • Patients who did not underwent coronary CT angiography, 1 month to 2 years prior to the acute myocardial infarction
  • Poor CT images (unable to reconstruct 3 dimensional coronary artery model)
  • The time period between coronary CT angiography and acute myocardial infarction exceed more than 2 years

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (2)

Seoul national university hospital

Seoul, 110-744, South Korea

Location

Samsung Medical Center

Seoul, 135-710, South Korea

Location

Related Publications (1)

  • Lee JM, Choi G, Koo BK, Hwang D, Park J, Zhang J, Kim KJ, Tong Y, Kim HJ, Grady L, Doh JH, Nam CW, Shin ES, Cho YS, Choi SY, Chun EJ, Choi JH, Norgaard BL, Christiansen EH, Niemen K, Otake H, Penicka M, de Bruyne B, Kubo T, Akasaka T, Narula J, Douglas PS, Taylor CA, Kim HS. Identification of High-Risk Plaques Destined to Cause Acute Coronary Syndrome Using Coronary Computed Tomographic Angiography and Computational Fluid Dynamics. JACC Cardiovasc Imaging. 2019 Jun;12(6):1032-1043. doi: 10.1016/j.jcmg.2018.01.023. Epub 2018 Mar 14.

MeSH Terms

Conditions

Acute Coronary SyndromeMyocardial InfarctionPlaque, AtheroscleroticRupture, Spontaneous

Condition Hierarchy (Ancestors)

Myocardial IschemiaHeart DiseasesCardiovascular DiseasesVascular DiseasesInfarctionIschemiaPathologic ProcessesPathological Conditions, Signs and SymptomsNecrosisPathological Conditions, Anatomical

Study Officials

  • Bon-Kwon Koo, MD, PhD

    Seoul National University Hospital

    STUDY CHAIR
  • Bon-Kwon Koo, MD, PhD

    Seoul National University Hospital

    PRINCIPAL INVESTIGATOR
  • Joo Myung Lee, MD, MPH

    Samsung Medical Center

    STUDY DIRECTOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor

Study Record Dates

First Submitted

September 22, 2014

First Posted

March 2, 2015

Study Start

September 1, 2014

Primary Completion

September 1, 2017

Study Completion

December 1, 2017

Last Updated

April 4, 2017

Record last verified: 2017-04

Data Sharing

IPD Sharing
Will share

After acceptance of first manuscript, the data will be shared upon request and permission of principal investigator and participants of the study

Locations